Pharmacokinetic (PK) Study of Single-dose Rosuvastatin and Tipranavir/Ritonavir in Healthy Subjects

NCT00344123 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Tipranavir/Ritonavir
DRUG: Rosuvastatin

Sponsor

Johns Hopkins University

Collaborators

[object Object]